Haloperidol
- Product NDC
- 59651-791
- 11-digit product format
- 596510791
- Labeler code
- 59651
- Product ID
- 59651-791_265a70c4-9b29-464c-9258-735bd2b2ccf7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Haloperidol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aurobindo Pharma Limited
- Application
- ANDA218789
- Marketing category
- ANDA
- Marketing start
- 2024-04-19
- Substance
- HALOPERIDOL
- Active strength
- 2 mg/1
- Pharmacologic classes
- Typical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Haloperidol
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| HALOPERIDOL | 2 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | J6292F8L3D |
| Rxcui | 197754, 310670, 310671, 310672, 314034, 314035 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 59651-791-01 | Haloperidol | 100 in 1 BOTTLE | TABLET | 100 | | 3 |
| 59651-791-99 | Haloperidol | 1000 in 1 BOTTLE | TABLET | 1000 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 59651-791 | HALOPERIDOL TABLET [AUROBINDO PHARMA LIMITED] | 3 | Current NDC, 2 package rows | 20241121_bf21633e-f37b-4017-a143-538eb005de2d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 59651-791-01 | 59651079101 | 100 TABLET in 1 BOTTLE (59651-791-01) | 100 tablet | 2024-04-19 | No | No | Historical |
| 59651-791-99 | 59651079199 | 1000 TABLET in 1 BOTTLE (59651-791-99) | 1000 tablet | 2024-04-19 | No | No | Historical |